Skip to main content
letter
. 2015 Feb 8;17(6):599–602. doi: 10.1111/dom.12435

Figure 1.

DOM-12435-FIG-0001-b

Mean changes in glycated haemoglobin (HbA1c) and lipid variables from baseline (lobeglitazone group, n = 128; pioglitazone group, n = 125). For the extension study, the results obtained for the 83 patients who continued lobeglitazone (lobeglitazone group) and the 94 patients who switched to lobeglitazone from pioglitazone (pioglitazone group) are shown.